Kevin G. Pinz

BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

Weijia Wang, Shanzhi He, Wenli Zhang et al. · Annals of the Rheumatic Diseases · 2024 · 196 citations

Life Sciences, Immunology, Molecular Medicine +17

Efficient Repair of Abasic Sites in DNA by Mitochondrial Enzymes

Kevin G. Pinz, Daniel Bogenhagen · Molecular and Cellular Biology · 1998 · 192 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor

Kevin H. Chen, M. Wada, Kevin G. Pinz et al. · Leukemia · 2017 · 182 citations · Full text

Life Sciences, Immunology, Oncology +16

First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

Fang Liu, Yuanzhen Cao, Kevin G. Pinz et al. · Blood · 2018 · 140 citations

Medicine, Hematology, Oncology +16

Action of Mitochondrial DNA Polymerase γ at Sites of Base Loss or Oxidative Damage

Kevin G. Pinz, Shinya Shibutani, Daniel Bogenhagen · Journal of Biological Chemistry · 1995 · 126 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17